About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
ecancer
ecancer.org
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
ELCC 2024
EAU 2024
ASCO GU 2024
ASCO GI 2024
AORTIC 2023
ASH 2023
SABCS 2023
ESMO 2023
Common Sense Oncology
WCLC 2023
ESMO WCGIC 2023
ASCO® 2023
EHA® 2023
ELCC 2023
ASCO GU 2023
BGICC 2023
ASCO GI 2023
SABCS 2022
ESMO 2022
WCLC 2022
EHA 2022
ASCO 2022
ASCO 2021
Lymphoma
Leukemia
Myeloma
GYN Cancers
Head&Neck Cancers
GI Cancers
Breast Cancers
GU Cancers
Lung Cancers
Skin Cancers
Basic Science
Supportive & Palliative Care
Business
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
O
ESMO 2023 Insights: "WSG-ADAPT Trial - Multiparametric Prognostic Score in Early HR+/HER2- BC"
By
ecancer
FEATURING
Oleg Gluz
By
ecancer
FEATURING
Oleg Gluz
71 views
December 7, 2023
0 Comments
Login to view comments.
Click here to Login
Featured Video
23:14
AstraZeneca Oncology
Management Strategies for Nausea and Vomiting in First-line Maintena…
Feat.
D. Czel,
C. Arn
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
ESMO 2023
17:34
ecancer
Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…
Feat.
L. Raez
07:29
ecancer
ESMO 2023 Insights: "BEATcc Trial - 1L Chemo With Atezolizumab …
Feat.
A. Oaknin
03:02
ecancer
ESMO 2023 Insights: "WSG-ADAPT Trial - Multiparametric Prognost…
Feat.
O. Gluz
08:15
ecancer
ESMO 2023 Summary: "Highlights From Recent NSCLC Trials"
Feat.
B. Gyawali
02:36
ecancer
ESMO 2023 Summary: "Highlights From Recent Prostate and Bladder…
Feat.
B. Gyawali
03:31
ecancer
ESMO 2023 Summary: "Highlights From Recent GI Cancer Trials&quo…
Feat.
B. Gyawali
07:32
ecancer
ESMO 2023 Summary: "CAR-T Therapy & Impact to Cancer Patien…
Feat.
M. Hellberg-Naegele
02:49
ecancer
ESMO 2023 Insights: "Alliance A021602 Study - Cabozantinib vs. …
Feat.
J. Chan
02:21
ecancer
ESMO 2023 Insights: "SWOG S1801 Study - Resectable Melanoma Tre…
Feat.
S. Patel
02:47
ecancer
ESMO 2023 Insights: "Tisotumab Vedotin vs. Investigator’s Choic…
Feat.
I. Vergote
02:38
ecancer
ESMO 2023 Insights: "Pembro + CRT For High-Risk Locally Advance…
Feat.
D. Lorusso
03:31
ecancer
ESMO 2023 Insights: "Benefit of Adjuvant RT Following Radical P…
Feat.
N. Clarke
03:00
ecancer
ESMO 2023 Insights: "Feasibility & Safety of Boost at 74 Gy…
Feat.
G. Zalcman
02:41
ecancer
ESMO 2023 Insights: "Survival Results for Neoadjuvant Cemiplima…
Feat.
N. Gross
03:53
ecancer
ESMO 2023 Insights: "ANITA Trial on Atezolizumab With Platinum-…
Feat.
A. González-Martín
01:59
ecancer
ESMO 2023 Insights: "Phase 3 GCIG INTERLACE Trial - Induction C…
Feat.
M. McCormack
19:46
ecancer
ESMO 2023 Summary: "PARPi Combinations to Treat Patients With m…
Feat.
A. Merseburger,
K. Fizazi,
L. Krabbe,
G. Attard
03:11
ecancer
ESMO 2023 Insights: "CodeBreak 300 Phase 3 Study - Sotorasib &a…
Feat.
F. Pietrantonio
06:42
ecancer
ESMO 2023 Insights: "LIBRETTO-431 Phase 3 Study of 1L Selpercat…
Feat.
H. Loong
03:36
ecancer
ESMO 2023 Insights: "Phase 3 TROPION-Breast01 Trial - Datopotam…
Feat.
A. Bardia
02:05
ecancer
ESMO 2023 Insights: "CheckMate 7FL Phase 3 Study - Nivo or Plac…
Feat.
S. Loi
05:21
ecancer
ESMO 2023 Insights: "Effects of Short-Term Fasting on Quality o…
Feat.
D. Koppold-Liebscher
13:29
ecancer
ESMO 2023 Insights: "Genomic Testing - Awareness & Effectiv…
Feat.
R. Simcock,
A. Cardone
04:57
ecancer
ESMO 2023 Insights: "Phase 3 LIBRETTO-531 Study - Selpercatinib…
Feat.
J. Hadoux
04:31
ecancer
ESMO 2023 Insights: "Phase III DUO-E/GOG-3041/ENGOT-EN10 Trial …
Feat.
S. Westin
02:07
ecancer
ESMO 2023 Insights: "CheckMate 901 Trial - Nivo+Gem-Cis vs. Gem…
Feat.
M. Van Der Heijden
22:00
ecancer
ESMO 2023 Insights: "A Biomarker-Led Approach to Bladder Cancer…
Feat.
A. Necchi,
G. De Velasco,
A. Siefker-Radtke,
Y. Loriot
19:02
ecancer
ESMO 2023 Insights: "Latest in EGFR Ex20ins Advanced NSCLC"
Feat.
A. Spira,
J. Sabari,
E. Felip
25:48
ecancer
ESMO 2023 Insights: "The Latest in NSCLC With Common EGFR Mutat…
Feat.
A. Addeo,
A. Passaro,
A. Spira,
A. Tufman
14:05
ecancer
ESMO 2023 Insights: "Phase 3 CheckMate-77T Study - Perioperativ…
Feat.
T. Cascone
02:35
ecancer
ESMO 2023 Insights: "Phase 2 KRYSTAL-7 Trial - Adagrasib+Pembro…
Feat.
P. Janne
06:01
ecancer
ESMO 2023 Insights: "Phase 3 EV-302 Trial - Evaluating the Comb…
Feat.
T. Powles
01:53
ecancer
ESMO 2023 Insights: "Results From Phase 2 LITESPARK-003 Study -…
Feat.
T. Choueiri
02:23
ecancer
ESMO 2023 Insights: "Comparing Belzutifan With Everolimus in Pr…
Feat.
T. Choueiri
